C9302 Inj zanidatamab, 2 mgInjection, zanidatamab-hrii, 2 mg
C9302 appears in 3 coverage policies from Blue Cross & Blue Shield of Mississippi, Wellmark Blue Cross Blue Shield.
| Payer | Policy | Role in policy | Reviewed | Document |
|---|---|---|---|---|
| Blue Cross & Blue Shield of Mississippi | Injectable Oncology (S.5.01.561) | not covered | payer document | |
| Blue Cross & Blue Shield of Mississippi | Injectable Oncology (L.5.01.561) | not covered | payer document | |
| Wellmark Blue Cross Blue Shield | Ziihera® (zanidatamab-hrii) (05.05.73) | listed, no stance | Aug 1, 2026 | payer document |
From payers' published prior-auth lists, coverage policies and state Medicaid fee schedules, updated Oct 16, 2026. The role is what the policy's own code table or text says about the code. Not a guarantee of coverage or payment; verify with the payer. CPT® is a registered trademark of the American Medical Association.